The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.85
Bid: 48.60
Ask: 48.70
Change: 0.00 (0.00%)
Spread: 0.10 (0.206%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.85
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM, Annual Report

20 Apr 2023 17:00

RNS Number : 9669W
IP Group PLC
20 April 2023
 

FOR RELEASE ON

20 April 2023

IP Group - 2022 Annual Report; Notice of Annual General Meeting ("AGM")

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces that it has published its Annual Report and Accounts for the year ended 31 December 2022.

 

In compliance with Listing Rule 9.6.3, a copy of the following documents will shortly be available for inspection at www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

- Annual Report and Accounts for the year ended 31 December 2022 ("2022 ARA"); and

- Notice of 2023 Annual General Meeting ("2023 AGM Notice").

 

Printed copies of the 2022 ARA and the 2023 AGM Notice, together with the Form of Proxy for use in connection with the 2023 AGM, have been posted to shareholders who have requested hard copies.

 

An electronic copy of the 2022 ARA is available on the Investor Relations section of the IP Group website at www.ipgroupplc.com/investor-relations. A copy of the 2023 AGM Notice is also available electronically on the IP Group website at https://www.ipgroupplc.com/investors/shareholder-information/agm The Dividend Mandate Form is also available on the Company's website at https://www.ipgroupplc.com/investors/shareholder-information/dividend.

 

The 2023 AGM will be held at 11.00am on 15 June 2023 at the Company's offices at 3 Pancras Square, King's Cross, London, N1C 4AG, as further set out in the 2023 AGM Notice. To ensure that shareholders can also follow the proceedings of the AGM virtually, the Company will provide access online via the Investor Meet Company platform. However, please note that shareholders will not be able to vote online at the AGM via the platform and are therefore requested to submit their votes via proxy, as early as possible, as further detailed in the 2023 AGM Notice.

The Company will also hold an investor event immediately before the AGM at which an update on the Group will be provided and shareholders will be able to ask questions of the Board. Any shareholder attending the AGM in person will be able to attend the shareholder event (and vice versa). The shareholder event will take place from 9.30am-10.30am (with refreshments available from 9.00am) and will also be streamed live to those who wish to attend virtually. 

Whilst live questions will be accepted on the day, in order to facilitate the smooth running of the shareholder event and AGM, shareholders are encouraged to submit any questions for the Board to consider via the Investor Meet Company Platform up until 9am the day before the AGM. Shareholders can also submit questions in advance by email to cosec@ipgroupplc.com up to 48 hours prior to the time of the AGM.

Shareholders that wish to attend the shareholder event and AGM remotely should register in advance by using the following link: https://www.investormeetcompany.com/ip-group-plc/register-investor.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Vic Wallin

Alex Donaldson

+44 (0) 7973 823119

+44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. Athe most active UK based, early stage science investorwe develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutionsOur specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAIMMATMTATBPJ
Date   Source Headline
26th Apr 20245:29 pmRNSTransaction in Own Shares
26th Apr 20243:36 pmRNSEmployee Share Schemes; Director/PDMR shareholding
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20246:05 pmRNSNotice of AGM, Annual Report
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20245:48 pmRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20245:56 pmRNSTransaction in Own Shares
9th Apr 20245:31 pmRNSTransaction in Own Shares
8th Apr 20245:32 pmRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20245:27 pmRNSTransaction in Own Shares
3rd Apr 20245:37 pmRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20245:30 pmRNSTransaction in Own Shares
25th Mar 20246:03 pmRNSTransaction in Own Shares
25th Mar 20248:54 amRNSDirector Declaration
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:56 pmRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20245:03 pmRNSDirector Declaration
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNS2023 Annual Results
12th Mar 20245:24 pmRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSCorrection - Holding(s) in Company
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20242:35 pmRNSHolding(s) in Company
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20245:02 pmRNSTransaction in Own Shares
4th Mar 20245:34 pmRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20249:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.